Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
56°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dexcom Inc
(NQ:
DXCM
)
69.56
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dexcom Inc
< Previous
1
2
...
17
18
19
20
21
22
23
24
Next >
2 Unstoppable Stocks to Buy and Hold for Decades
October 21, 2021
These are investments that you won't need to worry about.
Via
The Motley Fool
Analyst Ratings For DexCom
October 18, 2021
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) with...
Via
Benzinga
1 Supercharged Healthcare Stock to Buy Right Now
September 29, 2021
The stock isn't a household name, but it's generated multibagger returns over the past five years alone.
Via
The Motley Fool
Ignore GameStop: Here Are 2 Better Stocks
September 28, 2021
The performance of these two companies isn't detached from their financial results.
Via
The Motley Fool
Exposures
COVID-19
Dexcom Insider Sold Over $3.87 Million In Company Stock
September 27, 2021
Steven R Pacelli, Managing Dir. And Dexcom Ventures at Dexcom (NASDAQ:DXCM), made a large insider sell on September 23, according to a new SEC filing. What Happened: A Form 4...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Expert Ratings For DexCom
September 16, 2021
Within the last quarter, DexCom (NASDAQ:DXCM) has observed the following an...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Expert Ratings for DexCom
August 02, 2021
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) with...
Via
Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
Dexcom Insider Sold Over $3.24 Million In Company Stock
September 17, 2021
Kevin R Sayer, CEO And President at Dexcom (NASDAQ:DXCM), made a large insider sell on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S....
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Notable Dexcom Insider Makes $3.06 Million Sale
September 14, 2021
Andrew K Balo, * at Dexcom (NASDAQ:DXCM), made a large insider sell on September 9, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...
Via
Benzinga
Notable Dexcom Insider Makes $10.22 Million Sale
September 10, 2021
Quentin S Blackford, Chief Operating Officer at Dexcom (NASDAQ:DXCM), made a large insider sell on September 10, according to a new SEC filing. What Happened: A Form 4 filing...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
This Smart Monitor Company Has Outperformed Apple, Google And Amazon Over The Last 5 Years
September 08, 2021
A smart monitor company that received FDA approval in 2015 has seen a five-year stock performance that has outperformed the returns of Apple Inc (NASDAQ: AAPL), Alphabet Inc (...
Via
Benzinga
Exposures
Product Safety
Moderna And DexCom Lead The Nasdaq-100
September 01, 2021
U.S. indices had a mixed day of trading Wednesday as investors weigh rising COVID-19 Delta variant cases nationwide. The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained 0.17% to...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
Pool, Dexcom Lead Five Stocks Showing Tight, Bullish Action Near Buy Points
August 28, 2021
Tight trading is a bullish sign. Pool, Dexcom lead five stocks trading tightly near buy points.
Via
Investor's Business Daily
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...
Via
Benzinga
DexCom And O'Reilly Auto Parts Lead The QQQ Monday
August 16, 2021
U.S. indices bounced off Monday morning’s lows as investors weigh weak China retail and production data. Uncertainty around the COVID-19 Delta variant is also weighing on...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...
Via
Benzinga
Exposures
COVID-19
Product Safety
Unusual Options Activity Insight: DexCom
August 16, 2021
n Shares of DexCom (NASDAQ:DXCM) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $494.82. Sentiment: BULLISH Option...
Via
Benzinga
3 Growth Stocks to Buy and Hold Regardless of What Happens With the Delta Variant
August 10, 2021
These companies are still going to be great long-term buys.
Via
The Motley Fool
Topics
Economy
Exposures
COVID-19
Economy
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...
Via
Benzinga
2 Top Growth Stocks That Could Help Your Portfolio Shine
August 03, 2021
These two stocks have been moving in opposite directions of late.
Via
The Motley Fool
3 Stocks to Buy That Should Get a Boost From Pandemic-Driven Consumer Weight Gain
July 31, 2021
Athletic-apparel maker Lululemon and two diabetes specialists are poised to get a long-term tailwind from the COVID-19 pandemic.
Via
The Motley Fool
Exposures
COVID-19
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Dexcom Stock Jumps As Q2 Earnings Beats Street, Raises Guidance; Analysts Bump Up Target Price
July 30, 2021
Continuous glucose monitor developer Dexcom Inc (NASDAQ: DXCM) shares ticked up as second-quarter results easily topped the consensus forecast; adjusted EPS of...
Via
Benzinga
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Friday's Intraday Session
July 30, 2021
Gainers Erytech Pharma (NASDAQ:ERYP) sha...
Via
Benzinga
63 Biggest Movers From Friday
August 02, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
17
18
19
20
21
22
23
24
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.